Nicoderm: Clinical Trials

9 trials of Nicoderm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 unknown. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Terminated 2, Active not recruiting 1, Unknown 1
Phase 21Terminated 1

Follow Nicoderm: new trials by email Literature Review of Nicoderm trials Research Report on Nicoderm

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3CompletedRose Research Center, LLC1502024-08-292026-02-06
Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3TerminatedRose Research Center, LLC42023-12-272025-03-30
Optimizing Tobacco Use Treatment for PLWHA
Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence
Phase 3Active not recruitingAbramson Cancer Center at Penn Medicine3402020-02-172026-09-04
Individualizing Pharmacotherapy for African American Smokers
Nicotine patch, Varenicline Tartrate, Bupropion - Smoking Cessation
Phase 3CompletedUniversity of Kansas Medical Center3922019-05-012023-04-03
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence
Phase 2 / Phase 3TerminatedCentre for Addiction and Mental Health182015-07-012018-07-19
The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
Nicotine Replacement Therapy (NRT), Varenicline, HIV Tailored Quit Smoking Counseling - HIV, Smoking Cessation
Phase 3UnknownOttawa Hospital Research Institute2562014-01-012015-12-14
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University2822011-07-012017-11-14
Concurrent Bupropion / Varenicline for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University7022011-03-012014-08-06
Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study
Placebo (sugar pill), Topiramate, Nicotine patch - Tobacco Dependence
Phase 3CompletedUConn Health572006-04-012017-08-16

Conditions studied

Smoking Cessation (8)  ·  Tobacco Use Disorder (5)  ·  Cigarette Smoking (3)  ·  Harm Reduction (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Smoking (1)

Sponsors

Duke University (2)  ·  Rose Research Center, LLC (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Centre for Addiction and Mental Health (1)  ·  Ottawa Hospital Research Institute (1)  ·  UConn Health (1)  ·  University of Kansas Medical Center (1)

Countries

United States (7)  ·  Canada (2)

Top investigators

Cheryl A Oncken, MD (1)  ·  F. Joseph McClernon, Ph.D. (1)  ·  Jed E Rose, Ph.D. (1)  ·  Laurie Zawertailo, PhD (1)  ·  Louise Balfour, PhD (1)  ·  Nicole Nollen, PhD (1)  ·  Peter Selby, MBBS (1)  ·  Robert Schnoll, PhD (1)

Results publications

PMID 34611902, PMID 37142273, PMID 24057996, PMID 24934962, PMID 36387983, PMID 37338906, PMID 39976595

NIH funding

P50DA027840 (2), K24AA013736 (1), M01RR006192 (1), R01CA243914 (1), R01DA046576 (1)